National Institute of Diabetes and Digestive and Kidney Disorders, Notice of closed Meeting, 2702-2703 [07-235]
Download as PDF
2702
Federal Register / Vol. 72, No. 13 / Monday, January 22, 2007 / Notices
Complementary, and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, (301) 451–6570,
birkled@mail.nih.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meetings
rmajette on PROD1PC67 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meeting will be closed to the
public in accordance with the
provisions set forth in section 552b(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel, Clinical Science.
Date: February 25–27, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Jeanette M Hosseini, PhD.,
Scientific Review Administrator, Office of
Scientific Review, National Center for
Complementary, and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, (301) 594–9096,
jeanetteh@mail.nih.gov.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel, Training and
Education.
Date: March 5–6, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Laurie Friedman Donze,
PhD., Scientific Review Administrator, Office
of Scientific Review, National Center for
Complementary, and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, 301 402–1030,
donzel@mail.nih.gov.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel, Basic Science.
Date: March 12–13, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Dale L. Birkle, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Center for
VerDate Aug<31>2005
15:20 Jan 19, 2007
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–247 Filed 1–19–07; 8:45 am]
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute, Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; Heart, Lung, and
Blood Program Project Review Committee.
Date: March 15, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton College Park, 4095 Powder
Mill Road, Beltsville, MD 20705.
Contact Person: Jeffrey H. Hurst, PhD,
Scientific Review Administrator, Review
Branch, Division of Extramural Research
Activities, National Heart, Lung, and Blood
Institute/NIH, 6701 Rockledge Drive, RM
7208, Bethesda, MD 20892, (301) 435–0303,
hurstj@nhibi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–236 Filed 1–19–06; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group; Microbiology and Infectious Diseases
Research Committee, MIDRC February 2007.
Date: February 7–8, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Annie Walker-Abbey, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, NIH/NIAID/DHHS, 6700B
Rockledge Drive, RM. 3126, Bethesda, MD
20892–7616, 301–451–2671,
aabbey@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–234 Filed 1–19–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Disorders, Notice
of closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice
is hereby given of the following
meeting.
E:\FR\FM\22JAN1.SGM
22JAN1
Federal Register / Vol. 72, No. 13 / Monday, January 22, 2007 / Notices
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
National Institute of Arthritis and
Musculoskeletal and Skin Diseases,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIAMS.
Date: February 8–9, 2007.
Time: 1 p.m. to 1:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 4C32, Bethesda, MD 20892.
Contact Person: John J. O’Shea, MD, PhD,
Scientific Director, National Institute of
Arthritis & Musculoskeletal, and Skin
Diseases, Building 10, Room 9N228, MSC
1820, Bethesda, MD 20892, (301) 496–2612,
osheaj@arb.niams.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, ZEB1 OSR–D M1
Training Grants Review.
Date: February 27, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Hotel Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: John Hayes, Scientific
Review Administrator, 6707 Democracy
Blvd., Suite 959, Democracy Two, Bethesda,
MD 20892, (301) 451–3398,
hayesj@mail.nih.gov.
Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–242 Filed 1–19–07; 8:45 am]
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
meeting is to evaluate requests for
preclinical development resources for
potential new therapeutics for type 1
diabetes. The outcome of the evaluation
will be a decision whether NIDDK
should support the request and make
available contract resources for
development of the potential
therapeutic to improve the treatment or
prevent the development of type 1
diabetes and its complications. The
research proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the proposed research
projects, the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: Type 1 Diabetes—
Rapid Access to Intervention Development
Special Emphasis Panel; National Institute of
Diabetes and Digestive and Kidney Diseases.
Date: January 23, 2007.
Time: 3 p.m. to 4 p.m.
Agenda: To evaluate requests for
preclinical development resources for
potential new therapeutics for type 1 diabetes
and its complications.
Place: 6707 Democracy Boulevard,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Dr. Myrlene Staten, Senior
Advisor, Diabetes Transplation Research,
Division of Diabetes, Endocrinology and
Metabolic Diseases, NIDDK, NIH, 6707
Democracy Boulevard, Bethesda, MD 20892–
5460, 301 402–7886.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 98.849, Kidney Diseases, urology
and Hematology Research, National Institutes
of Health, HHS)
This notice is being published less
than 15 days prior to the meeting due
to the timing limitations imposed by the
review and funding cycle.
rmajette on PROD1PC67 with NOTICES
Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–235 Filed 1–19–07; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
15:20 Jan 19, 2007
Jkt 211001
2703
National Institutes of Health
Dated: January 12, 2007.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–238 Filed 1–19–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, NIAMS.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel, Development of an ELISA
for Measuring Serum Levels.
Date: February 8, 2007.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate contract
proposals.
E:\FR\FM\22JAN1.SGM
22JAN1
Agencies
[Federal Register Volume 72, Number 13 (Monday, January 22, 2007)]
[Notices]
[Pages 2702-2703]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-235]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney
Disorders, Notice of closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice is hereby given of the following
meeting.
[[Page 2703]]
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The purpose of this meeting is to evaluate requests
for preclinical development resources for potential new therapeutics
for type 1 diabetes. The outcome of the evaluation will be a decision
whether NIDDK should support the request and make available contract
resources for development of the potential therapeutic to improve the
treatment or prevent the development of type 1 diabetes and its
complications. The research proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the proposed research projects, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Type 1 Diabetes--Rapid Access to Intervention
Development Special Emphasis Panel; National Institute of Diabetes
and Digestive and Kidney Diseases.
Date: January 23, 2007.
Time: 3 p.m. to 4 p.m.
Agenda: To evaluate requests for preclinical development
resources for potential new therapeutics for type 1 diabetes and its
complications.
Place: 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Dr. Myrlene Staten, Senior Advisor, Diabetes
Transplation Research, Division of Diabetes, Endocrinology and
Metabolic Diseases, NIDDK, NIH, 6707 Democracy Boulevard, Bethesda,
MD 20892-5460, 301 402-7886.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 98.849, Kidney Diseases, urology
and Hematology Research, National Institutes of Health, HHS)
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and funding
cycle.
Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-235 Filed 1-19-07; 8:45 am]
BILLING CODE 4140-01-M